NAN: Strong FY26 results with record trophon growth, CORIS launch, and 8–12% FY27 revenue guidanceQuartr·Aug 25 at 02:33 AM
NAN: Revenue up 3% to $203.9m, $20m buyback completed, CORIS launch on track for FY27Quartr·Aug 24 at 10:30 PM
NAN: FY27 guidance targets 8–12% revenue growth and increased CORIS investment, with a $40M buybackQuartr·Aug 24 at 10:29 PM
Weekend Wrap: Six dogs, five compounders and nine chartsMarket Index·Jul 25 at 10:30 PMAMCR-1.69%CSLLY+1.28%
Sona Nanotech’s Hyperthermia Platform Boosts Immunotherapy Response in Colorectal Cancer StudyTip Ranks·Apr 7 at 01:58 PM
Nanologica Reports Minor Neighboring Lab Incident With No Operational DamageTip Ranks·Mar 29 at 08:32 PM
